NanoRepro Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
NanoRepro's earnings have been declining at an average annual rate of -20.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 1.1% per year.
Anahtar bilgiler
-20.6%
Kazanç büyüme oranı
-19.5%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 4.3% |
Gelir büyüme oranı | 1.1% |
Özkaynak getirisi | -8.2% |
Net Marj | -89.8% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Cautious Investors Not Rewarding NanoRepro AG's (ETR:NN6) Performance Completely
Mar 01The Market Lifts NanoRepro AG (ETR:NN6) Shares 28% But It Can Do More
Sep 13A Look At The Intrinsic Value Of NanoRepro AG (ETR:NN6)
Aug 04NanoRepro (ETR:NN6) Is Experiencing Growth In Returns On Capital
Apr 12NanoRepro (ETR:NN6) Is Doing The Right Things To Multiply Its Share Price
Dec 15Robust Earnings May Not Tell The Whole Story For NanoRepro (ETR:NN6)
May 29NanoRepro AG's (ETR:NN6) Stock Is Going Strong: Have Financials A Role To Play?
Jan 04Gelir ve Gider Dağılımı
NanoRepro nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 4 | -3 | 5 | 0 |
31 Mar 24 | 3 | -4 | 5 | 0 |
31 Dec 23 | 3 | -5 | 4 | 0 |
30 Sep 23 | 9 | -6 | 3 | 0 |
30 Jun 23 | 14 | -7 | 2 | 0 |
31 Mar 23 | 27 | -5 | 2 | 0 |
31 Dec 22 | 39 | -4 | 2 | 0 |
30 Sep 22 | 54 | 0 | 2 | 0 |
30 Jun 22 | 69 | 4 | 2 | 0 |
31 Mar 22 | 116 | 17 | 3 | 0 |
31 Dec 21 | 163 | 30 | 3 | 0 |
30 Sep 21 | 149 | 29 | 2 | 0 |
30 Jun 21 | 135 | 27 | 2 | 0 |
31 Mar 21 | 76 | 14 | 2 | 0 |
31 Dec 20 | 17 | 2 | 1 | 0 |
30 Sep 20 | 10 | 1 | 1 | 0 |
30 Jun 20 | 3 | 0 | 1 | 0 |
31 Mar 20 | 2 | -1 | 1 | 0 |
31 Dec 19 | 2 | -1 | 1 | 0 |
30 Sep 19 | 2 | -1 | 1 | 0 |
30 Jun 19 | 2 | -1 | 1 | 0 |
31 Mar 19 | 2 | -1 | 1 | 0 |
31 Dec 18 | 3 | 0 | 1 | 0 |
30 Sep 18 | 3 | 0 | 1 | 0 |
30 Jun 18 | 3 | -1 | 1 | 0 |
31 Mar 18 | 2 | -1 | 1 | 0 |
31 Dec 17 | 2 | -1 | 1 | 0 |
30 Sep 17 | 2 | -1 | 1 | 0 |
30 Jun 17 | 2 | 0 | 1 | 0 |
31 Mar 17 | 2 | -1 | 1 | 0 |
31 Dec 16 | 2 | -1 | 1 | 0 |
30 Sep 16 | 1 | -1 | 1 | 0 |
30 Jun 16 | 1 | -1 | 1 | 0 |
31 Mar 16 | 1 | -1 | 1 | 0 |
31 Dec 15 | 1 | -1 | 0 | 0 |
30 Sep 15 | 1 | -1 | 1 | 0 |
30 Jun 15 | 1 | -1 | 0 | 0 |
31 Mar 15 | 1 | 0 | 0 | 0 |
31 Dec 14 | 1 | 0 | 0 | 0 |
30 Sep 14 | 1 | 0 | 0 | 0 |
30 Jun 14 | 0 | 0 | 0 | 0 |
31 Mar 14 | 1 | 0 | 0 | 0 |
31 Dec 13 | 2 | 0 | 0 | 0 |
Kaliteli Kazançlar: NN6 is currently unprofitable.
Büyüyen Kar Marjı: NN6 is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: NN6 is unprofitable, and losses have increased over the past 5 years at a rate of 20.6% per year.
Büyüme Hızlandırma: Unable to compare NN6's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: NN6 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Özkaynak Getirisi
Yüksek ROE: NN6 has a negative Return on Equity (-8.2%), as it is currently unprofitable.